Search 25,000+ prices/
Medicine prices in Saudi Arabia

Infliximab Price in Saudi Arabia (2026)

Compiled by the TrustClinix data team · Medical review pending2 official sourcesPrices last checked 25 October 2026How we get our data
Lowest SFDA public price
SAR 1,357

Cheapest pack: Remsima 100 Mg Powder For Solution For Infusion, 100 mg · powder for concentrate for solution for infusion. Official public price list, Oct 2026.

≈ $362
SAR 1,089 – SAR 2,964
per pack
1
strength
7
listed products
public price
price type
What you actually pay

What a patient pays for infliximab in Saudi Arabia

SAR 1,357
official public price for Remsima 100 Mg Powder For Solution For Infusion
Up to SAR 1,357
you pay at the pharmacy

Registered public price: the most a pharmacy may charge. Insurance or government care may cover it.

7 products

7 different brand names across 1 strength are on the official list.

Every listed product

All 7 infliximab products in Saudi Arabia

Infliximab official prices in Saudi Arabia
ProductStrength (as listed) · formPackPricePer unit
Remsima 100 Mg Powder For Solution For Infusion100 mg · powder for concentrate for solution for infusion—SAR 1,357—
Remicade 100Mg Vial For Inj100 mg · powder for concentrate for solution for infusion—SAR 1,485—
Renflexis100 · powder for concentrate for solution for infusion—SAR 1,089—
Ixifi100 · powder for concentrate for solution for infusion—SAR 1,451—
Remsima Sc120 · solution for injection—SAR 2,964—
Remsima Sc With Needle Guard120 · solution for injection—SAR 2,964—
Remsima Sc Auto Injector Pre-Filled Pen120 · solution for injection—SAR 2,964—
What this price means

How public prices work in Saudi Arabia

Prices on this page are the registered public price per pack listed by the Saudi Food and Drug Authority (SFDA). Pharmacies may not sell above this price. Insurance or government hospitals may cover the cost for eligible patients.

Read the full guide to medicine prices in Saudi Arabia.

Strengths and forms

Every strength and form of infliximab in Saudi Arabia

Strengths and forms
Strength and formProductsCheapest packCheapest per unit
injection5SAR 1,089—
100 mg injection2SAR 1,357—

Different strengths and forms (for example slow-release or dissolving tablets) are not interchangeable without your doctor's advice.

Brand names

Brands of infliximab in Saudi Arabia

6 brand names of infliximab are on the official list in Saudi Arabia. Each brand page shows every pack and the cheapest alternative with the same strength.

A–Z

Other medicine prices in Saudi Arabia

Keep exploring

What people check next

Quick answers

Frequently asked questions

How much does infliximab cost in Saudi Arabia?
Official public prices for infliximab in Saudi Arabia range from SAR 1,357 to SAR 2,964 per pack across 7 listed products.
What kind of price is this?
It is the registered public price per pack listed by the Saudi Food and Drug Authority (SFDA). Pharmacies may not sell above this price. Insurance or government hospitals may cover the cost for eligible patients.
How much will I pay for infliximab at a pharmacy in Saudi Arabia?
Up to SAR 1,357 for Remsima 100 Mg Powder For Solution For Infusion. Registered public price: the most a pharmacy may charge. Insurance or government care may cover it.
What brands of infliximab are sold in Saudi Arabia?
6 brand names are on the official list, including Renflexis (from SAR 1,089), Remsima (from SAR 1,357), Ixifi (from SAR 1,451), Remicade (from SAR 1,485) and Remsima Sc (from SAR 2,964).
Evidence

Sources

  1. Saudi Food and Drug Authority (SFDA). Registered Drugs List with public prices. www.sfda.gov.sa/en/drugs-list. Retrieved 25 October 2026.
  2. Central Bank of the UAE; Saudi Central Bank (SAMA). Fixed US dollar pegs: 1 USD = 3.6725 AED; 1 USD = 3.75 SAR. www.centralbank.ae/en/. Retrieved 25 October 2026.

Important: These are published reference prices and estimates, not a quote, and not medical advice. Actual costs depend on the hospital, your health, the exact treatment and your insurance. Always confirm the price with the provider before treatment. Read our disclaimer · Report an error